CareRx（CHHH.F）株式概要ケアレックス・コーポレーションは、その子会社とともに、カナダの高齢者施設やその他の集合介護施設に薬局サービスを提供している。 詳細CHHH.F ファンダメンタル分析スノーフレーク・スコア評価5/6将来の成長0/6過去の実績4/6財務の健全性4/6配当金3/6報酬当社が推定した公正価値より75%で取引されている 今年は黒字化を達成 アナリストらは、株価が46.5%上昇するだろうとほぼ一致している。 リスク分析今後3年間の収益は年平均54.6%減少すると予測されている。 株式の流動性は非常に低い すべてのリスクチェックを見るCHHH.F Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$2.5520.9% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-39m456m2016201920222025202620282031Revenue CA$456.5mEarnings CA$33.0mAdvancedSet Fair ValueView all narrativesCareRx Corporation 競合他社Blum HoldingsSymbol: OTCPK:BLMHMarket cap: US$7.9mG. Willi-Food InternationalSymbol: NasdaqCM:WILCMarket cap: US$494.4mDingdong (Cayman)Symbol: NYSE:DDLMarket cap: US$557.2mVillage Super MarketSymbol: NasdaqGS:VLGE.AMarket cap: US$687.4m価格と性能株価の高値、安値、推移の概要CareRx過去の株価現在の株価CA$2.5552週高値CA$2.8952週安値CA$1.97ベータ0.621ヶ月の変化-5.48%3ヶ月変化n/a1年変化n/a3年間の変化n/a5年間の変化-48.32%IPOからの変化-90.87%最新ニュースお知らせ • May 11CareRx Corporation announces Quarterly dividend, payable on July 09, 2026CareRx Corporation announced Quarterly dividend of CAD 0.0200 per share payable on July 09, 2026, ex-date on June 23, 2026 and record date on June 23, 2026.お知らせ • Apr 28CareRx Corporation to Report Q1, 2026 Results on May 06, 2026CareRx Corporation announced that they will report Q1, 2026 results After-Market on May 06, 2026お知らせ • Mar 17CareRx Corporation, Annual General Meeting, May 28, 2026CareRx Corporation, Annual General Meeting, May 28, 2026.お知らせ • Mar 10CareRx Corporation announces Quarterly dividend, payable on April 09, 2026CareRx Corporation announced Quarterly dividend of CAD 0.0200 per share payable on April 09, 2026, ex-date on March 19, 2026 and record date on March 19, 2026.お知らせ • Feb 25CareRx Corporation to Report Q4, 2025 Results on Mar 04, 2026CareRx Corporation announced that they will report Q4, 2025 results After-Market on Mar 04, 2026お知らせ • Dec 17CareRx Corporation announces Quarterly dividend, payable on January 21, 2026CareRx Corporation announced Quarterly dividend of CAD 0.0200 per share payable on January 21, 2026, ex-date on December 23, 2025 and record date on December 23, 2025.最新情報をもっと見るRecent updatesお知らせ • May 11CareRx Corporation announces Quarterly dividend, payable on July 09, 2026CareRx Corporation announced Quarterly dividend of CAD 0.0200 per share payable on July 09, 2026, ex-date on June 23, 2026 and record date on June 23, 2026.お知らせ • Apr 28CareRx Corporation to Report Q1, 2026 Results on May 06, 2026CareRx Corporation announced that they will report Q1, 2026 results After-Market on May 06, 2026お知らせ • Mar 17CareRx Corporation, Annual General Meeting, May 28, 2026CareRx Corporation, Annual General Meeting, May 28, 2026.お知らせ • Mar 10CareRx Corporation announces Quarterly dividend, payable on April 09, 2026CareRx Corporation announced Quarterly dividend of CAD 0.0200 per share payable on April 09, 2026, ex-date on March 19, 2026 and record date on March 19, 2026.お知らせ • Feb 25CareRx Corporation to Report Q4, 2025 Results on Mar 04, 2026CareRx Corporation announced that they will report Q4, 2025 results After-Market on Mar 04, 2026お知らせ • Dec 17CareRx Corporation announces Quarterly dividend, payable on January 21, 2026CareRx Corporation announced Quarterly dividend of CAD 0.0200 per share payable on January 21, 2026, ex-date on December 23, 2025 and record date on December 23, 2025.お知らせ • Oct 24CareRx Corporation to Report Q3, 2025 Results on Nov 03, 2025CareRx Corporation announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Nov 03, 2025お知らせ • Sep 17CareRx Corporation announces Quarterly dividend, payable on October 15, 2025CareRx Corporation announced Quarterly dividend of CAD 0.0200 per share payable on October 15, 2025, ex-date on September 23, 2025 and record date on September 23, 2025.お知らせ • Jul 21CareRx Corporation to Report Q2, 2025 Results on Jul 30, 2025CareRx Corporation announced that they will report Q2, 2025 results After-Market on Jul 30, 2025お知らせ • May 01CareRx Corporation to Report Q1, 2025 Results on May 07, 2025CareRx Corporation announced that they will report Q1, 2025 results at 7:00 AM, US Eastern Standard Time on May 07, 2025お知らせ • Mar 25CareRx Corporation, Annual General Meeting, Jun 05, 2025CareRx Corporation, Annual General Meeting, Jun 05, 2025.お知らせ • Feb 26CareRx Corporation to Report Q4, 2024 Results on Mar 05, 2025CareRx Corporation announced that they will report Q4, 2024 results at 7:00 AM, US Eastern Standard Time on Mar 05, 2025お知らせ • Oct 31CareRx Corporation to Report Q3, 2024 Results on Nov 08, 2024CareRx Corporation announced that they will report Q3, 2024 results at 7:00 AM, Eastern Standard Time on Nov 08, 2024お知らせ • Sep 05CareRx Corporation Appoints Suzanne Brand as Chief Financial Officer, Effective October 1, 2024CareRx Corporation announced that following an extensive executive search process, Suzanne Brand will be joining the Company in the role of Chief Financial Officer effective October 1, 2024. Ms. Brand is a highly accomplished executive, bringing a wealth of financial, healthcare and leadership experience. She joins CareRx from Teva Pharmaceuticals, a leading global manufacturer of quality generic and innovative pharmaceuticals, where she has held several senior finance roles since 2011, most recently serving as CFO of Teva Canada. Prior to joining Teva, Ms. Brand spent twelve years in finance at Wyeth Pharmaceuticals, a Pfizer company, where she held senior roles including as a Director, Commercial and Corporate Finance. She began her career as an auditor at PriceWaterhouseCoopers (PwC). Ms. Brand is a Chartered Professional Accountant (CPA) and Chartered Accountant (CA) and holds a Bachelor of Science degree in Biology and Business from the University of Toronto.お知らせ • Aug 02CareRx Corporation to Report Q2, 2024 Results on Aug 08, 2024CareRx Corporation announced that they will report Q2, 2024 results at 7:00 AM, US Eastern Standard Time on Aug 08, 2024お知らせ • May 30CareRx Corporation Announces Board ChangesCareRx Corporation announced that as part of the Company's commitment to Board refreshment and to realign Board functions to match the Company's strategic focus on operational performance, Kevin Dalton, Chairman of the Board for the last six years, will be retiring as Chairman effectively immediately. Mr. Dalton will be succeeded by Jeff Watson, a current independent director of the Board. Mr. Dalton will be stepping into the role as Chair of the Compensation, Nominating and Governance Committee in place of Maria Perrella, who will continue to remain Chair of the Audit Committee. Mr. Watson has served on the Board of CareRx since 2023 and brings over three decades of experience in the healthcare industry, having most recently served as the President and CEO of Apotex from 2018 to 2023. Mr. Watson currently represents SK Capital Partners on two of their portfolio company boards for Apotex and Woodstock Sterile Solutions, and has previously served on numerous other boards, including as a board member and Chair of the Association for Accessible Medicines (AAM), Chair of the Canadian Generic Pharmaceutical Association (CGPA), and former Chair of the US Healthcare Distribution Alliance's (HDA) knowledge partner, the HDA Research Foundation.お知らせ • May 15CareRx Corporation Announces CFO TransitionCareRx Corporation announced that Andrew Mok will step down as Chief Financial Officer effective June 7, 2024, to pursue another employment opportunity. The Company is undertaking a search for a new CFO. Davide Pernarella, currently Vice President, Business Planning and Analysis at CareRx, will assume the role of Interim Chief Financial Officer following Mr. Mok's departure. Mr. Pernarella has worked at CareRx for over seven years in various roles with increasing responsibility, and has an intimate knowledge of the financial and business affairs of the Company. Prior to joining CareRx, he held roles in the Transaction Services and Assurance groups at KPMG Canada. Mr. Pernarella is a Chartered Professional Accountant (CPA) and Chartered Accountant (CA) and holds a Bachelor of Commerce degree from the Rotman School of Management at the University of Toronto.お知らせ • Mar 15CareRx Corporation, Annual General Meeting, May 28, 2024CareRx Corporation, Annual General Meeting, May 28, 2024.お知らせ • Mar 08CareRx Corporation Reports Goodwill and Intangible Assets Impairment Charges for the Fourth Quarter Ended December 31, 2023CareRx Corporation reported goodwill and intangible assets impairment of $710,000 for the fourth quarter ended December 31, 2023.お知らせ • Mar 01CareRx Corporation to Report Q4, 2023 Results on Mar 07, 2024CareRx Corporation announced that they will report Q4, 2023 results at 7:00 AM, US Eastern Standard Time on Mar 07, 2024お知らせ • Nov 02CareRx Corporation to Report Q3, 2023 Results on Nov 08, 2023CareRx Corporation announced that they will report Q3, 2023 results at 7:00 AM, US Eastern Standard Time on Nov 08, 2023お知らせ • Aug 04CareRx Corporation to Report Q2, 2023 Results on Aug 10, 2023CareRx Corporation announced that they will report Q2, 2023 results at 7:00 AM, US Eastern Standard Time on Aug 10, 2023お知らせ • Jun 07Carerx Corporation Announces Director ChangesCareRx Corporation appointed Puneet Khanna and Jeff Watson as directors. Company announced that Matt Hills did not stand for re-election.お知らせ • Jan 19CareRx Corporation has completed a Follow-on Equity Offering in the amount of CAD 8.0001 million.CareRx Corporation has completed a Follow-on Equity Offering in the amount of CAD 8.0001 million. Security Name: Common Shares Security Type: Common Stock Securities Offered: 2,963,000 Price\Range: CAD 2.7 Discount Per Security: CAD 0.162お知らせ • May 21CareRx Corporation announced that it has received CAD 63.250644 million in funding from Yorkville Asset Management Inc.On May 19, 2021, CareRx Corporation (TSX:CRRX) closed the transaction. The company issued a total of 12,524,880 subscription receipts for gross proceeds of CAD 63,250,644. The transaction included a portion of non-brokered placement from returning investor Yorkville Asset Management Inc. for 2,277,230 subscription receipts for proceeds of CAD 11,500,011.5 and brokered portion of 10,247,650 subscription receipts for proceeds of CAD 51,750,632.5.株主還元CHHH.FUS Consumer RetailingUS 市場7D-0.4%-5.2%1.0%1Yn/a14.6%28.7%株主還元を見る業界別リターン: CHHH.FがUS Consumer Retailing業界に対してどのようなパフォーマンスを示したかを判断するにはデータが不十分です。リターン対市場: CHHH.F US市場に対してどのようなパフォーマンスを示したかを判断するにはデータが不十分です。価格変動Is CHHH.F's price volatile compared to industry and market?CHHH.F volatilityCHHH.F Average Weekly Movementn/aConsumer Retailing Industry Average Movement5.2%Market Average Movement7.2%10% most volatile stocks in US Market16.4%10% least volatile stocks in US Market3.1%安定した株価: CHHH.Fの株価は、 US市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 過去 1 年間のCHHH.Fのボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイト20011,483Puneet Khannawww.carerx.caCareRx Corporationは、その子会社とともに、カナダの高齢者施設やその他の集会施設に薬局サービスを提供している。同社は投薬管理、テクノロジー、プログラムサービスを提供している。介護施設、老人ホーム、福祉施設、グループホームにサービスを提供している。旧社名はセントリック・ヘルス・コーポレーションで、2020年6月にケアレックス・コーポレーションに社名変更した。CareRx Corporationは2001年に法人化され、カナダのトロントに本社を置いている。もっと見るCareRx Corporation 基礎のまとめCareRx の収益と売上を時価総額と比較するとどうか。CHHH.F 基礎統計学時価総額US$163.04m収益（TTM）US$19.59m売上高(TTM)US$271.17m8.2xPER（株価収益率0.6xP/SレシオCHHH.F は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計CHHH.F 損益計算書（TTM）収益CA$374.61m売上原価CA$261.88m売上総利益CA$112.74mその他の費用CA$85.67m収益CA$27.07m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）0.43グロス・マージン30.09%純利益率7.23%有利子負債／自己資本比率36.1%CHHH.F の長期的なパフォーマンスは？過去の実績と比較を見る配当金2.3%現在の配当利回り14%配当性向CHHH.F 配当は確実ですか？CHHH.F 配当履歴とベンチマークを見るCHHH.F 、いつまでに購入すれば配当金を受け取れますか？CareRx 配当日配当落ち日Jun 23 2026配当支払日Jul 09 2026配当落ちまでの日数31 days配当支払日までの日数47 daysCHHH.F 配当は確実ですか？CHHH.F 配当履歴とベンチマークを見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 04:04終値2026/05/22 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋CareRx Corporation 7 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。11 アナリスト機関Kyle McPheeATB CormarkKyle McPheeATB Cormark Historical (Cormark Securities)Doug CooperBeacon Securities Limited8 その他のアナリストを表示
お知らせ • May 11CareRx Corporation announces Quarterly dividend, payable on July 09, 2026CareRx Corporation announced Quarterly dividend of CAD 0.0200 per share payable on July 09, 2026, ex-date on June 23, 2026 and record date on June 23, 2026.
お知らせ • Apr 28CareRx Corporation to Report Q1, 2026 Results on May 06, 2026CareRx Corporation announced that they will report Q1, 2026 results After-Market on May 06, 2026
お知らせ • Mar 17CareRx Corporation, Annual General Meeting, May 28, 2026CareRx Corporation, Annual General Meeting, May 28, 2026.
お知らせ • Mar 10CareRx Corporation announces Quarterly dividend, payable on April 09, 2026CareRx Corporation announced Quarterly dividend of CAD 0.0200 per share payable on April 09, 2026, ex-date on March 19, 2026 and record date on March 19, 2026.
お知らせ • Feb 25CareRx Corporation to Report Q4, 2025 Results on Mar 04, 2026CareRx Corporation announced that they will report Q4, 2025 results After-Market on Mar 04, 2026
お知らせ • Dec 17CareRx Corporation announces Quarterly dividend, payable on January 21, 2026CareRx Corporation announced Quarterly dividend of CAD 0.0200 per share payable on January 21, 2026, ex-date on December 23, 2025 and record date on December 23, 2025.
お知らせ • May 11CareRx Corporation announces Quarterly dividend, payable on July 09, 2026CareRx Corporation announced Quarterly dividend of CAD 0.0200 per share payable on July 09, 2026, ex-date on June 23, 2026 and record date on June 23, 2026.
お知らせ • Apr 28CareRx Corporation to Report Q1, 2026 Results on May 06, 2026CareRx Corporation announced that they will report Q1, 2026 results After-Market on May 06, 2026
お知らせ • Mar 17CareRx Corporation, Annual General Meeting, May 28, 2026CareRx Corporation, Annual General Meeting, May 28, 2026.
お知らせ • Mar 10CareRx Corporation announces Quarterly dividend, payable on April 09, 2026CareRx Corporation announced Quarterly dividend of CAD 0.0200 per share payable on April 09, 2026, ex-date on March 19, 2026 and record date on March 19, 2026.
お知らせ • Feb 25CareRx Corporation to Report Q4, 2025 Results on Mar 04, 2026CareRx Corporation announced that they will report Q4, 2025 results After-Market on Mar 04, 2026
お知らせ • Dec 17CareRx Corporation announces Quarterly dividend, payable on January 21, 2026CareRx Corporation announced Quarterly dividend of CAD 0.0200 per share payable on January 21, 2026, ex-date on December 23, 2025 and record date on December 23, 2025.
お知らせ • Oct 24CareRx Corporation to Report Q3, 2025 Results on Nov 03, 2025CareRx Corporation announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Nov 03, 2025
お知らせ • Sep 17CareRx Corporation announces Quarterly dividend, payable on October 15, 2025CareRx Corporation announced Quarterly dividend of CAD 0.0200 per share payable on October 15, 2025, ex-date on September 23, 2025 and record date on September 23, 2025.
お知らせ • Jul 21CareRx Corporation to Report Q2, 2025 Results on Jul 30, 2025CareRx Corporation announced that they will report Q2, 2025 results After-Market on Jul 30, 2025
お知らせ • May 01CareRx Corporation to Report Q1, 2025 Results on May 07, 2025CareRx Corporation announced that they will report Q1, 2025 results at 7:00 AM, US Eastern Standard Time on May 07, 2025
お知らせ • Mar 25CareRx Corporation, Annual General Meeting, Jun 05, 2025CareRx Corporation, Annual General Meeting, Jun 05, 2025.
お知らせ • Feb 26CareRx Corporation to Report Q4, 2024 Results on Mar 05, 2025CareRx Corporation announced that they will report Q4, 2024 results at 7:00 AM, US Eastern Standard Time on Mar 05, 2025
お知らせ • Oct 31CareRx Corporation to Report Q3, 2024 Results on Nov 08, 2024CareRx Corporation announced that they will report Q3, 2024 results at 7:00 AM, Eastern Standard Time on Nov 08, 2024
お知らせ • Sep 05CareRx Corporation Appoints Suzanne Brand as Chief Financial Officer, Effective October 1, 2024CareRx Corporation announced that following an extensive executive search process, Suzanne Brand will be joining the Company in the role of Chief Financial Officer effective October 1, 2024. Ms. Brand is a highly accomplished executive, bringing a wealth of financial, healthcare and leadership experience. She joins CareRx from Teva Pharmaceuticals, a leading global manufacturer of quality generic and innovative pharmaceuticals, where she has held several senior finance roles since 2011, most recently serving as CFO of Teva Canada. Prior to joining Teva, Ms. Brand spent twelve years in finance at Wyeth Pharmaceuticals, a Pfizer company, where she held senior roles including as a Director, Commercial and Corporate Finance. She began her career as an auditor at PriceWaterhouseCoopers (PwC). Ms. Brand is a Chartered Professional Accountant (CPA) and Chartered Accountant (CA) and holds a Bachelor of Science degree in Biology and Business from the University of Toronto.
お知らせ • Aug 02CareRx Corporation to Report Q2, 2024 Results on Aug 08, 2024CareRx Corporation announced that they will report Q2, 2024 results at 7:00 AM, US Eastern Standard Time on Aug 08, 2024
お知らせ • May 30CareRx Corporation Announces Board ChangesCareRx Corporation announced that as part of the Company's commitment to Board refreshment and to realign Board functions to match the Company's strategic focus on operational performance, Kevin Dalton, Chairman of the Board for the last six years, will be retiring as Chairman effectively immediately. Mr. Dalton will be succeeded by Jeff Watson, a current independent director of the Board. Mr. Dalton will be stepping into the role as Chair of the Compensation, Nominating and Governance Committee in place of Maria Perrella, who will continue to remain Chair of the Audit Committee. Mr. Watson has served on the Board of CareRx since 2023 and brings over three decades of experience in the healthcare industry, having most recently served as the President and CEO of Apotex from 2018 to 2023. Mr. Watson currently represents SK Capital Partners on two of their portfolio company boards for Apotex and Woodstock Sterile Solutions, and has previously served on numerous other boards, including as a board member and Chair of the Association for Accessible Medicines (AAM), Chair of the Canadian Generic Pharmaceutical Association (CGPA), and former Chair of the US Healthcare Distribution Alliance's (HDA) knowledge partner, the HDA Research Foundation.
お知らせ • May 15CareRx Corporation Announces CFO TransitionCareRx Corporation announced that Andrew Mok will step down as Chief Financial Officer effective June 7, 2024, to pursue another employment opportunity. The Company is undertaking a search for a new CFO. Davide Pernarella, currently Vice President, Business Planning and Analysis at CareRx, will assume the role of Interim Chief Financial Officer following Mr. Mok's departure. Mr. Pernarella has worked at CareRx for over seven years in various roles with increasing responsibility, and has an intimate knowledge of the financial and business affairs of the Company. Prior to joining CareRx, he held roles in the Transaction Services and Assurance groups at KPMG Canada. Mr. Pernarella is a Chartered Professional Accountant (CPA) and Chartered Accountant (CA) and holds a Bachelor of Commerce degree from the Rotman School of Management at the University of Toronto.
お知らせ • Mar 15CareRx Corporation, Annual General Meeting, May 28, 2024CareRx Corporation, Annual General Meeting, May 28, 2024.
お知らせ • Mar 08CareRx Corporation Reports Goodwill and Intangible Assets Impairment Charges for the Fourth Quarter Ended December 31, 2023CareRx Corporation reported goodwill and intangible assets impairment of $710,000 for the fourth quarter ended December 31, 2023.
お知らせ • Mar 01CareRx Corporation to Report Q4, 2023 Results on Mar 07, 2024CareRx Corporation announced that they will report Q4, 2023 results at 7:00 AM, US Eastern Standard Time on Mar 07, 2024
お知らせ • Nov 02CareRx Corporation to Report Q3, 2023 Results on Nov 08, 2023CareRx Corporation announced that they will report Q3, 2023 results at 7:00 AM, US Eastern Standard Time on Nov 08, 2023
お知らせ • Aug 04CareRx Corporation to Report Q2, 2023 Results on Aug 10, 2023CareRx Corporation announced that they will report Q2, 2023 results at 7:00 AM, US Eastern Standard Time on Aug 10, 2023
お知らせ • Jun 07Carerx Corporation Announces Director ChangesCareRx Corporation appointed Puneet Khanna and Jeff Watson as directors. Company announced that Matt Hills did not stand for re-election.
お知らせ • Jan 19CareRx Corporation has completed a Follow-on Equity Offering in the amount of CAD 8.0001 million.CareRx Corporation has completed a Follow-on Equity Offering in the amount of CAD 8.0001 million. Security Name: Common Shares Security Type: Common Stock Securities Offered: 2,963,000 Price\Range: CAD 2.7 Discount Per Security: CAD 0.162
お知らせ • May 21CareRx Corporation announced that it has received CAD 63.250644 million in funding from Yorkville Asset Management Inc.On May 19, 2021, CareRx Corporation (TSX:CRRX) closed the transaction. The company issued a total of 12,524,880 subscription receipts for gross proceeds of CAD 63,250,644. The transaction included a portion of non-brokered placement from returning investor Yorkville Asset Management Inc. for 2,277,230 subscription receipts for proceeds of CAD 11,500,011.5 and brokered portion of 10,247,650 subscription receipts for proceeds of CAD 51,750,632.5.
